We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.21B
AUM Growth
-$220M
Cap. Flow
+$134M
Cap. Flow %
11.11%
Top 10 Hldgs %
68.51%
Holding
46
New
2
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NET icon
Cloudflare
NET
+$78.5M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$51.4M
3
XENE icon
Xenon Pharmaceuticals
XENE
+$3.97M
4
MRSN
Mersana Therapeutics
MRSN
+$202K
5
TRVI icon
Trevi Therapeutics
TRVI
+$62.8K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 90.68%
2 Technology 6.97%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$178M 14.77%
2,268,188
– –
RARX
2
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$145M 12.02%
6,138,797
– –
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$7.4B
$106M 8.78%
4,912,306
– –
CRSP icon
4
CRISPR Therapeutics
CRSP
$4.64B
$85.7M 7.1%
2,090,678
– –
NET icon
5
Cloudflare
NET
$94.5B
$75.4M 6.24%
+4,059,376
New +$78.5M
ARDX icon
6
Ardelyx
ARDX
$1.24B
$72.1M 5.97%
15,335,047
– –
EPZM
7
DELISTED
Epizyme, Inc
EPZM
$45.2M 3.74%
4,377,518
– –
MIRM icon
8
Mirum Pharmaceuticals
MIRM
$6.72B
$42.1M 3.49%
+4,187,801
New +$51.4M
CBIO
9
Crescent Biopharma
CBIO
$595M
$39.2M 3.24%
90,890
– –
OBSV
10
DELISTED
ObsEva SA Ordinary Shares
OBSV
$38.2M 3.16%
4,586,563
– –
SENS icon
11
Senseonics Holdings Inc
SENS
$254M
$30.6M 2.53%
1,544,413
– –
PHAS
12
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$27.7M 2.29%
6,643,704
– –
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.92B
$27.6M 2.29%
5,172,683
– –
MRKR icon
14
Marker Therapeutics
MRKR
$20.2M
$25.6M 2.12%
500,000
– –
ADAP
15
DELISTED
Adaptimmune Therapeutics
ADAP
$23.9M 1.98%
15,832,611
– –
DERM
16
DELISTED
Dermira, Inc.
DERM
$22.4M 1.86%
3,506,649
– –
AVEO
17
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$21.3M 1.77%
2,524,387
– –
GNCA
18
DELISTED
Genocea Biosciences, Inc.
GNCA
$21M 1.74%
7,225,676
– –
TRVI icon
19
Trevi Therapeutics
TRVI
$2.6B
$20M 1.65%
4,441,360
+11,556
+0.3% +$62.8K
MRSN
20
DELISTED
Mersana Therapeutics
MRSN
$18.9M 1.57%
478,546
+2,775
+0.6% +$202K
AFMD
21
DELISTED
Affimed
AFMD
$15.1M 1.25%
513,889
– –
TPST icon
22
Tempest Therapeutics
TPST
$14.1M
$12.6M 1.04%
9,060
– –
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
$9.9M 0.82%
4,141,308
– –
SYBX
24
DELISTED
Synlogic
SYBX
$9.69M 0.8%
281,961
– –
LITS
25
Lite Strategy Inc
LITS
$33.2M
$9.61M 0.8%
286,029
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q3 2019 Portfolio in Review

As of Q3 2019, NEA Management Company held 46 positions worth $1.21B, down 15% from $1.43B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

NEA Management Company deployed $134M of net new capital in Q3 2019, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Cloudflare: 4,059,376 shares worth $75.4M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

  • NEA Management Company's largest Q3 2019 buy was Cloudflare: 4,059,376 shares worth $75.4M.
  • NEA Management Company added most to Xenon Pharmaceuticals in Q3 2019, an estimated $3.97M increase.
  • NEA Management Company's ten largest holdings make up 69% of its $1.21B portfolio in Q3 2019.
  • NEA Management Company opened 2 new positions and closed 0 in Q3 2019.
  • NEA Management Company's portfolio value fell 15% quarter-over-quarter to $1.21B.

Based on NEA Management Company's 13F filing for Q3 2019, filed 11 Oct 2019.